Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Keywords

Cystectomy, Medicine, Bladder cancer, Vinblastine, Urology

References

• Manual for Staging of CancerOliver H. Beahrs, Donald E. Henson — 1992
• A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Patrick J. Loehrer, Lawrence H. Einhorn, Paul Elson — 1992
• Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome.H.W. Herr, Dean F. Bajorin, Howard I. Scher — 1998
• A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.C. Logothetis, F. H. Dexeus, Laura Finn — 1990
• Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseCora N. Sternberg, Alan Yagoda, Howard I. Scher — 1989
• Epidemiology and prevention of bladder cancer.Eva Negri, Carlo La Vecchia — 2001
• Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort.Pierfrancesco Bassi, Gianluca Drago Ferrante, N. Piazza — 1999
• Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.Stuart Pocock, Richard Simon — 1975
• Cancer Statistics, 2001Robert T. Greenlee, M. B. Hill-Harmon, Thomas S. Murray — 2001
• Adjuvant and neoadjuvant chemotherapy for invasive bladder cancerRonald B. Natale — 2000
• Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study.Joseph A. Smith, E. David Crawford, Jorge C. Paradelo — 1997
• Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.Donald L. Lamm, Brent A. Blumenstein, John D. Crissman — 2000
• Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.Cora N. Sternberg, Alan Yagoda, Howard I. Scher — 1985
• Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer.Donald G. Skinner, Gary Lieskovsky — 1984
• A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Scher Hi — 1992
• Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC.Michael J. Droller — 2002
• Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.Griffiths, Gareth — 1999

Cited by

• Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling.Е. Г. Тоцкая, Elmira Khafizova, М. А. Садовой — 2006
• Laparoscopic lymph node dissection in urologic cancer.博雅 竹下, 実子 岩永, 勝己 鈴木 — 2005
• Systemic chemotherapy for urothelial cancer.Carlo Ferdinando Russo — 2006
• Importance of node dissection in relation to neoadjuvant and adjuvant therapy.Françoise Wuilmart — 2006
• Neoadjuvant chemotherapy for bladder transitional cell carcinoma: a new standard of care?G. A. Kyrala, S. Glenzer, N. B. Meezan — 2007
• Urinary diversion: options, patient selection, and outcomes.原田美歩 — 2007
• Long‐term follow up of patients with invasive bladder carcinoma receiving combined cisplatin‐based intra‐arterial chemotherapy and radiotherapyM. Dolors Pallarès i Ramon — 2007
• Urothelial carcinoma of the bladder: definition, treatment and future effortsMonte V. Davis, G.J. Dau, William Bernard Haidler — 2011
• Neoadjuvant Chemotherapy for Invasive Bladder CancerOlga Sitchevska — 2012
• The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancerElisenda Salavedra Boillos, Miquel Salinas Salvà — 2013
• Actionable mutations in muscle-invasive bladder cancerJoseph Opatoshu — 2013
• The future of bladder cancer care in the USASabas Martín Fuentes — 2014
• Controversies in the treatment of invasive urothelial carcinoma: a case report and review of the literatureV. Kerry Smith, William H. Desvousges, Ann Fisher — 2015
• Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settingsLindsay Dunbar — 2015
• Robot‐assisted radical cystectomyPingping Han — 2015
• Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder CancerEmilio Miraflores Gómez — 2016
• Toward personalized management in bladder cancer: the promise of novel molecular taxonomyMarie‐Lisa Eich, Lars Dyrskjøt, George J. Netto — 2017
• Expression of PDL1 (B7-H1) Before and After Neoadjuvant Chemotherapy in Urothelial Carcinoma.John C. Whitener — 2016
• Bladder cancer: Present and future.A Soleimannejad, P Hamdami, H Soudi — 2017
• Atezolizumab in invasive and metastatic urothelial carcinomaSunarto Sunarto — 2017

Related papers

• Bladder preservation protocols in the management of muscle-invasive bladder cancer: A systematic reviewShridhar C. Ghagane, Srikanth Pentyala, Rajendra B. Nerli — 2018
• Clinical study of partial cystectomy combined with chemotherapy for muscle-invasive bladder cancerHuang Yi-ran — 2012
• POD-09.06: Radical cystectomy in nonmuscle invasive bladder cancerS.A. El Abd, Asmaa Ramadan, M. Elsharaby — 2007
• High-Risk Non-Muscle Invasive Bladder Cancer: Selecting the Appropriate Patient for Timely Cystectomy.George E. Koch, Amy N. Luckenbaugh, Sam S. Chang — 2020
• Management of invasive bladder cancer in patients who are not candidates for or decline cystectomyArjun Vasant Balar, Dean F. Bajorin, Matthew I. Milowsky — 2011
• What Role for Radical Cystectomy for Muscle-Invasive Bladder Cancer?Robert Dreicer, FACP. FACP. — 2010
• The Role and Importance of Timely Radical Cystectomy for High-Risk Non-muscle-Invasive Bladder Cancer.Daniel J. Lee, Sam S. Chang — 2018